On the Need to Restrict the Opportunity of Investing in Securities of Medical Cannabis (Marijuana) Manufacturers in the Russian Federation

Abstract

The purpose of the work is to substantiate the need to regulate the securities market associated with producers of medical cannabis (marijuana). Until now, organizations and individuals with the status of a qualified investor can freely acquire, own, and dispose of shares of companies engaged in the production of narcotic drugs based on plant cannabinoids. As a methodological basis, Russian legislation was studied as it relates to professional participants in the securities market engaged in brokerage activities. The Strategy of the state anti-drug policy of the Russian Federation until 2030 was carefully analyzed in terms of threats to national security and the possibility of implementing the mechanisms of this program. Based on the results of the work, the conclusion was formulated that the problem voiced in the article requires an early response from the official authorities. The scientific significance lies in the argumentation of the need to create an interdepartmental commission from representatives of the state, commercial structures and society to formulate general decisions on the problem disclosed in the article. The practical significance lies in the recommendations to the Bank of Russia to consider the possibility of developing instruments that exclude investments in the assets of producers of medical cannabis (marijuana), as well as providing a comfortable time corridor for exiting such assets.